Cilloni D - Search Results

1

Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.

Cilloni D, Messa E, Messa F, Carturan S, Defilippi I, Arruga F, Rosso V, Catalano R, Bracco E, Nicoli P, Saglio G. Cilloni D, et al. Ann N Y Acad Sci. 2006 Nov;1089:411-23. doi: 10.1196/annals.1386.030. Ann N Y Acad Sci. 2006. PMID: 17261784 Review.

2

Molecular events in chronic myeloid leukemia progression.

Guerrasio A, Serra A, Gottardi E, Cilloni D, Vischia F, Parvis G, Cilli V, Saglio G. Guerrasio A, et al. Among authors: cilloni d. Leukemia. 1997 Apr;11 Suppl 3:519-21. Leukemia. 1997. PMID: 9209443

3

From genes to therapy: the case of Philadelphia chromosome-positive leukemias.

Cilloni D, Guerrasio A, Giugliano E, Scaravaglio P, Volpe G, Rege-Cambrin G, Saglio G. Cilloni D, et al. Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x. Ann N Y Acad Sci. 2002. PMID: 12095956

4

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.

Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio G. Cilloni D, et al. Leukemia. 2002 Oct;16(10):2115-21. doi: 10.1038/sj.leu.2402675. Leukemia. 2002. PMID: 12357365

5

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G; Piedmont Study Group on Myleodysplastic Syndromes. Cilloni D, et al. J Clin Oncol. 2003 May 15;21(10):1988-95. doi: 10.1200/JCO.2003.10.503. J Clin Oncol. 2003. PMID: 12743153

6

Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.

Cilloni D, Saglio G. Cilloni D, et al. Semin Hematol. 2003 Apr;40(2 Suppl 2):37-41. doi: 10.1053/shem.2003.50040. Semin Hematol. 2003. PMID: 12783374 Review.

7

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.

Cilloni D, Gottardi E, Fava M, Messa F, Carturan S, Busca A, Guerrasio A, Saglio G. Cilloni D, et al. Blood. 2003 Jul 15;102(2):773-4; author reply 774. doi: 10.1182/blood-2003-03-0980. Blood. 2003. PMID: 12835231 Free article. No abstract available.

8

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.

Cilloni D, Carturan S, Gottardi E, Messa F, Messa E, Fava M, Diverio D, Guerrasio A, Lo-Coco F, Saglio G. Cilloni D, et al. Blood. 2003 Oct 1;102(7):2705-6. doi: 10.1182/blood-2003-07-2256. Blood. 2003. PMID: 14504076 Free article. No abstract available.

9

Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment.

Saglio G, Cilloni D. Saglio G, et al. Among authors: cilloni d. Haematologica. 2004 Jan;89(1):6-9. Haematologica. 2004. PMID: 14754599 Review. No abstract available.

10

Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.

Cilloni D, Carturan S, Gottardi E, Messa F, Fava M, Defilippi I, Arruga F, Saglio G. Cilloni D, et al. Blood. 2004 Mar 15;103(6):2428; author reply 2429. doi: 10.1182/blood-2003-10-3488. Blood. 2004. PMID: 14998918 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters